Currency: SGD
Period
FY2023 Annual Report
--
0.00
-0.39
No Data
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
CytoMed Therapeutics | 6-K/A: Report of foreign private issuer (related to financial reporting)
Apr 26 03:36
CytoMed Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Apr 25 04:19
CytoMed Therapeutics | 20-F: Registration statement / Annual report / Transition report
Apr 23 05:27
Nov 17, 2023 22:33
Read more